Market Alert: Trump’s Tariff Policy Pressures Healthcare Stocks

Noble Helium Arranges AU$1.46 Million Loan to Refinance Debt and Strengthen Liquidity.

Oct 07, 2025

Noble Helium Limited (ASX: NHE) has finalized an AU$1.46 million loan agreement with shareholder Mr. Duncan MacNiven to fully settle its outstanding convertible note facility with Obsidian Global GP, LLC. The repayment will discharge all securities over the company’s assets and conclude the prior facility. The new loan is non-convertible, carries a 12% annual interest rate payable quarterly, and is due for repayment by 30 June 2027. It will be secured by a floating charge over the company’s assets. The funds will not only refinance existing debt but also enhance Noble Helium’s working capital position, supporting ongoing operations and exploration activities.

The agreement includes standard terms and conditions, covering repayment obligations, default events, and termination provisions, ensuring sound financial management and transparency. This strategic refinancing move strengthens Noble Helium’s balance sheet and positions it for stable future growth.

 

 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com